Respiratory synctial virus infection in BALB/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern
Authors:
- 1 May 1996
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 70 (5) , 2852-60
Abstract
Vaccination with formalin-inactivated respiratory syncytial virus (FI-RSV) caused excessive disease in infants upon subsequent natural infection with RSV. Recent studies with BALB/c mice have suggested that T cells are important contributors to lung immunopathology during RSV infection. In this study, we investigated vaccine-induced enhanced disease by immunizing BALB/c mice with live RSV intranasally or with FI-RSV intramuscularly. The mice were challenged with RSV 6 weeks later, and the pulmonary inflammatory response was studied by analyzing cells obtained by bronchoalveolar lavage 4 and 8 days after challenge. FI-RSV-immunized mice had an increased number of total cells, granulocytes, eosinophils, and CD4+ cells but a decreased number of CD8+ cells. The immunized mice also had a marked increase in the expression of mRNA for the Th2-type cytokines interleukin-5 (IL-5) and IL-13 as well as some increase in the expression of IL-10 (a Th2-type cytokine) mRNA and some decrease in the expression of IL-12 (a Th1-type cytokine) mRNA. The clear difference in the pulmonary inflammatory response to RSV between FI-RSV- and live-RSV-immunized mice suggests that this model can be used to evaluate the disease-enhancing potential of candidate RSV vaccines and better understand enhanced disease.Keywords
This publication has 32 references indexed in Scilit:
- In vivo production of tumour necrosis factor-α and interleukin-6 in BALB/c mice inoculated intranasally with a high dose of respiratory syncytial virusJournal of Medical Virology, 1994
- Lymphocyte responses and cytokinesCell, 1994
- Enhanced pulmonary pathology associated with the use of formalin-inactivated respiratory syncytial virus vaccine in cotton rats is not a unique viral phenomenonVaccine, 1993
- Lack of detectable enhanced pulmonary histopathology in cotton rats immunized with purified F glycoprotein of respiratory syncytial virus (RSV) when challenged at 3–6 months after immunizationVaccine, 1993
- Comparison of the ability of formalin-inactivated respiratory syncytial virus, immunopurified F, G and N proteins and cell lysate to enhance pulmonary changes in Balb/c miceVaccine, 1992
- Shedding of infectious virus and virus antigen during acute infection with respiratory syncytial virusJournal of Medical Virology, 1992
- Mucosal T cell distribution during infection with respiratory syncytial virusJournal of Medical Virology, 1992
- Pulmonary epithelial T cells induced by viral infection express T cell receptors α/βEuropean Journal of Immunology, 1991
- Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors.Journal of Experimental Medicine, 1988
- The Nuclear Segmentation of Eosinophils under Normal and Pathological ConditionsActa Haematologica, 1967